SICILIANO, Angela
 Distribuzione geografica
Continente #
EU - Europa 1.734
NA - Nord America 1.621
AS - Asia 1.315
SA - Sud America 191
AF - Africa 22
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.888
Nazione #
US - Stati Uniti d'America 1.596
GB - Regno Unito 532
CN - Cina 476
SG - Singapore 463
RU - Federazione Russa 458
HK - Hong Kong 172
BR - Brasile 160
IT - Italia 157
SE - Svezia 127
IE - Irlanda 104
DE - Germania 91
FI - Finlandia 86
FR - Francia 85
VN - Vietnam 80
ID - Indonesia 25
JP - Giappone 23
UA - Ucraina 23
KR - Corea 21
CA - Canada 19
AT - Austria 18
IN - India 18
BE - Belgio 13
AR - Argentina 12
NL - Olanda 11
EC - Ecuador 6
TR - Turchia 6
PL - Polonia 5
TG - Togo 5
ZA - Sudafrica 5
BD - Bangladesh 4
GR - Grecia 4
IR - Iran 4
LT - Lituania 4
MA - Marocco 4
MX - Messico 4
VE - Venezuela 4
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
ES - Italia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 4.888
Città #
Southend 466
Chandler 224
Singapore 201
Hong Kong 171
Dallas 169
Jacksonville 147
Moscow 119
Ashburn 107
Ann Arbor 105
Dublin 104
Beijing 92
Woodbridge 86
Houston 63
Verona 59
New York 45
Wilmington 40
Dong Ket 37
Jinan 35
Los Angeles 35
Lawrence 33
Princeton 33
Shenyang 30
Nanjing 27
Helsinki 25
Jakarta 25
Hebei 24
The Dalles 21
Tokyo 21
Lancaster 20
Munich 20
Buffalo 15
Hangzhou 15
Zhengzhou 15
Collegeville 14
Vienna 14
São Paulo 13
Turku 13
Brussels 12
Columbus 12
Guangzhou 12
Haikou 12
Nanchang 12
Ningbo 12
Redmond 12
Redondo Beach 12
Changsha 11
Falls Church 11
Bologna 10
Tianjin 10
Ho Chi Minh City 9
Nuremberg 9
London 8
Montreal 8
San Francisco 8
Sindelfingen 8
Taiyuan 8
Taizhou 8
Boardman 7
Chicago 7
Jiaxing 7
Milan 7
Rome 7
Cambridge 6
Catanzaro 6
Chennai 6
Denver 6
Norwalk 6
Santa Clara 6
Seattle 6
Amsterdam 5
Lappeenranta 5
Lomé 5
Padova 5
Phoenix 5
Redwood City 5
Renton 5
Campinas 4
Fuzhou 4
Johannesburg 4
Toronto 4
Warsaw 4
Xi'an 4
Atlanta 3
Belo Horizonte 3
Boston 3
Brasília 3
Brooklyn 3
Camerino 3
Clearwater 3
Dongguan 3
Falkenstein 3
Frankfurt am Main 3
Kent 3
Kochi 3
Lanzhou 3
Lanús 3
Las Vegas 3
Meda 3
Porto Alegre 3
Registro 3
Totale 3.077
Nome #
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 244
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 182
Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy 175
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial 161
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 158
Resveratrol Induces Erythroid Maturation by Activating FOXO3 and Improves in Vivo Erythropoiesis in Normal and Beta -Thalassemic Mice 154
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 154
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 153
K-Cl cotransport (KCC) plays an important role in normal and b thalassemic erythropoiesis 150
Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. 145
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 141
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 137
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 136
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 130
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 129
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 129
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 128
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 128
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 127
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 126
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 123
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 123
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 119
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 116
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 113
Regulation of K-Cl cotransport by protein phosphatase 1alpha in mouse erythrocytes 111
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 105
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 102
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 102
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 101
Peroxiredoxin-2 (Prx2) expression is increased in beta thalassemic mouse red cells but displaced from the membrane as marker of oxidative stress 98
Red Blood Cell Homeostasis: Pharmacological Interventions to Explore Biochemical, Morphological and Mechanical Properties. 84
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 83
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 81
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 67
Duality of Nrf2 in iron-overload cardiomyopathy 64
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 63
17(R)-Resolvin d1 protects against sickle cell- related inflammatory cardiomyopathy in humanized mice 62
Nrf2 Plays a Key Role in Erythropoiesis during Aging 60
In humanized sickle cell mice, imatinib protects against sickle cell-related injury 51
Mitapivat metabolically reprograms human beta-thalassemic erythroblasts, increasing their responsiveness to oxidation 44
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 34
Pharmacological Inhibition of Calpain-1 Prevents Red Cell Dehydration and Reduces Gardos Channel Activity in a Mouse Model of Sickle Cell Disease. Identification of Druggable Protease Target 30
PEROXIREDOXIN-2 (Prx2) MEMBRANE DISPLACEMENT IS A NEW ADDITIONAL FACTOR to the SEVERITY of beta-THALASSEMIC MOUSE RED CELL MEMBRANE DAMAGE 28
Totale 4.951
Categoria #
all - tutte 16.905
article - articoli 14.754
book - libri 0
conference - conferenze 2.151
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 31 32 8 14 12 4 35 71
2021/2022294 26 97 9 18 15 6 4 15 14 5 18 67
2022/2023642 35 96 56 99 60 164 2 30 65 6 16 13
2023/2024383 16 24 24 33 43 55 3 18 2 26 112 27
2024/20251.001 55 36 36 162 39 62 82 29 148 73 94 185
2025/20261.041 192 130 197 483 39 0 0 0 0 0 0 0
Totale 4.951